Health Care Innovation
Business & Economics
Pharmaceutical Price Controls Will Not Improve Health Care Outcomes in Illinois
Due to its national implications, last week’s introduction of the Department of Health and Human Services’ (HHS) blueprint on drug prices is garnering all the attention. Despite its importance, HHS’ blueprint should not overshadow the many poor, and even unconstitutional, policy proposals that are occurring at the state level. For ...
Business & Economics
Creating an Affordable Health Care System Requires More than Rounding Up the Usual Suspects
Health care is becoming less affordable every year. Over the past 10 years, national healthcare expenditures have grown 45 percent, but our economy has grown only 28 percent. This isn’t sustainable; and, solving this problem should be a top policy priority. However, “rounding up the usual suspects,” as Captain Renault ...
Book
Sally Pipes Releases New Book The False Promise of Single-Payer Health Care
As the political drumbeat for single-payer health care rises in Sacramento, other states around the country, and in Washington, DC, PRI’s Sally Pipes today released a new book that makes the case for why single-payer health care would be a disaster for all Americans, The False Promise of Single-Payer Health ...
Commentary
Myths and Realities of the Health Care Affordability Problem
According to the five-second rule, you can still eat your food that has fallen on the floor, so long as you picked it up within five seconds. Only, this common perception is bad advice. In reality, if a person eats food that has fallen on a dirty floor, he risks ...
Commentary
Keep Big Government Out of Medicare Drug Pricing Negotiations
Tomorrow, the Senate Health, Education, Labor & Pensions Committee (HELP) will discuss a proposed alteration to Medicare. The proposal comes from a report released in late November by the National Academies of Sciences, Engineering, and Medicine. NASEM urges Congress to allow federal bureaucrats to negotiate Medicare drug prices directly with pharmaceutical companies. Currently, private insurance ...
Blog
PRI-Manhattan Institute Forum Addresses California’s Drug Pricing Challenge
Earlier this week, PRI joined with the Manhattan Institute to host a well-attended Sacramento panel discussion on California’s drug pricing challenge. Many thanks to my friend and former longtime Capitol reporter Marcey Brightwell, who did an outstanding job moderating the event. Drug pricing emerged as one of the hottest issues ...
Blog
The Price Control Hammer Will Break the Health Care System
From California to Washington D.C. legislators continue to confirm Abraham Kaplan’s famous insight that if you, “give a small boy a hammer, he will find that everything he encounters needs pounding.” In the case of our legislators, that hammer is price controls; and, what needs pounding is the price of ...
Business & Economics
Price Controls Will Reduce Innovation and Health Outcomes
Abraham Kaplan famously noted that if you, “give a small boy a hammer, he will find that everything he encounters needs pounding.” Put differently, solving problems requires the right tool, not the convenient tool. Congress should remember this wisdom in its upcoming deliberations regarding the cost of prescription drugs. The ...
Blog
Price Transparency Occurs in Markets, Not Government Offices
The wrong model, no matter how hard it is worked, always provides the wrong answer. And, so it is with a bill being considered in Sacramento (SB 17). SB 17 is supposed to address the problem of skyrocketing health care costs by requiring pharmaceutical manufacturers to give 60-day notice for ...
Commentary
Here’s What Single-Payer Advocates Don’t Want You To Know
Single-payer is back on the docket in California. Late last month, Assembly Speaker Anthony Rendon announced that he’d formed a special committee “to develop plans for achieving universal health care in California.” Rendon has been under pressure from progressive activists all summer, ever since he shelved SB 562, a bill ...
Pharmaceutical Price Controls Will Not Improve Health Care Outcomes in Illinois
Due to its national implications, last week’s introduction of the Department of Health and Human Services’ (HHS) blueprint on drug prices is garnering all the attention. Despite its importance, HHS’ blueprint should not overshadow the many poor, and even unconstitutional, policy proposals that are occurring at the state level. For ...
Creating an Affordable Health Care System Requires More than Rounding Up the Usual Suspects
Health care is becoming less affordable every year. Over the past 10 years, national healthcare expenditures have grown 45 percent, but our economy has grown only 28 percent. This isn’t sustainable; and, solving this problem should be a top policy priority. However, “rounding up the usual suspects,” as Captain Renault ...
Sally Pipes Releases New Book The False Promise of Single-Payer Health Care
As the political drumbeat for single-payer health care rises in Sacramento, other states around the country, and in Washington, DC, PRI’s Sally Pipes today released a new book that makes the case for why single-payer health care would be a disaster for all Americans, The False Promise of Single-Payer Health ...
Myths and Realities of the Health Care Affordability Problem
According to the five-second rule, you can still eat your food that has fallen on the floor, so long as you picked it up within five seconds. Only, this common perception is bad advice. In reality, if a person eats food that has fallen on a dirty floor, he risks ...
Keep Big Government Out of Medicare Drug Pricing Negotiations
Tomorrow, the Senate Health, Education, Labor & Pensions Committee (HELP) will discuss a proposed alteration to Medicare. The proposal comes from a report released in late November by the National Academies of Sciences, Engineering, and Medicine. NASEM urges Congress to allow federal bureaucrats to negotiate Medicare drug prices directly with pharmaceutical companies. Currently, private insurance ...
PRI-Manhattan Institute Forum Addresses California’s Drug Pricing Challenge
Earlier this week, PRI joined with the Manhattan Institute to host a well-attended Sacramento panel discussion on California’s drug pricing challenge. Many thanks to my friend and former longtime Capitol reporter Marcey Brightwell, who did an outstanding job moderating the event. Drug pricing emerged as one of the hottest issues ...
The Price Control Hammer Will Break the Health Care System
From California to Washington D.C. legislators continue to confirm Abraham Kaplan’s famous insight that if you, “give a small boy a hammer, he will find that everything he encounters needs pounding.” In the case of our legislators, that hammer is price controls; and, what needs pounding is the price of ...
Price Controls Will Reduce Innovation and Health Outcomes
Abraham Kaplan famously noted that if you, “give a small boy a hammer, he will find that everything he encounters needs pounding.” Put differently, solving problems requires the right tool, not the convenient tool. Congress should remember this wisdom in its upcoming deliberations regarding the cost of prescription drugs. The ...
Price Transparency Occurs in Markets, Not Government Offices
The wrong model, no matter how hard it is worked, always provides the wrong answer. And, so it is with a bill being considered in Sacramento (SB 17). SB 17 is supposed to address the problem of skyrocketing health care costs by requiring pharmaceutical manufacturers to give 60-day notice for ...
Here’s What Single-Payer Advocates Don’t Want You To Know
Single-payer is back on the docket in California. Late last month, Assembly Speaker Anthony Rendon announced that he’d formed a special committee “to develop plans for achieving universal health care in California.” Rendon has been under pressure from progressive activists all summer, ever since he shelved SB 562, a bill ...
